Peter MacCallum Centre of Excellence in Cellular Immunotherapy

We are excited to hear about the latest funding boost to Peter MacCallum Cancer Institute to become a Centre of Excellence in CAR T-Cell therapy.  More patients will soon have access to life-changing immunotherapy clinical trials thanks to a $105 million co-investment announced by Greg Hunt MP and the Commonwealth Government.

This significant $80 million government investment, with input from Peter Mac and the Peter Mac Foundation, will provide access to treatments previously only offered overseas, making Melbourne a global hub for immunotherapy.

As with other cancer types, we hold out hope that this therapy could be manipulated and researched to have effect on NET cancers.

Read news story from Peter Mac here

Peter Mac

Share this article

Subscribe to our Newsletter

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Related News

NECA Joins Boehringer Ingelheim Panel Discussion on Clinical Trials and Patient Access

Expressions of interest open for ANZSNM nurse and allied health workshop in Canberra

NECA partners with Oncidium ahead of World Radiotheranostics Day 2026

Bringing Together Experts to Improve NET Patient Care: NECA at the 5th NET Preceptorship

Tax Appeal

Screenshot 2026-05-20 at 2.12.07 PM

Help 31,000+ neuroendocrine cancer patients get the specialised care they deserve.

Every dollar raised is fully tax deductible and helps fund much needed advocacy efforts and patient support.